Warner & Kaine Applaud $35 Monthly Insulin Caps by Largest Insulin Manufacturers Following Inflation Reduction Act Implementation
January 02, 2024
January 02, 2024
WASHINGTON, Jan. 2 -- Sen. Mark Warner, D-Virginia, issued the following news release:
U.S. Sens. Mark R. Warner and Tim Kaine--who serves on the Senate Health, Education, Labor and Pensions Committee--released the following statements applauding Eli Lilly, Novo Nordisk, and Sanofi for officially lowering the cost of their insulin products to $35 per month for most patients. The companies' moves, which came in 2023 for Eli Lilly and January 1, 2024 for Novo Nordisk and Sanofi, . . .
U.S. Sens. Mark R. Warner and Tim Kaine--who serves on the Senate Health, Education, Labor and Pensions Committee--released the following statements applauding Eli Lilly, Novo Nordisk, and Sanofi for officially lowering the cost of their insulin products to $35 per month for most patients. The companies' moves, which came in 2023 for Eli Lilly and January 1, 2024 for Novo Nordisk and Sanofi, . . .